S Pyörälä Selected Research

Mastitis

08/2004	The efficacy of bovine lactoferrin in the treatment of cows with experimentally induced Escherichia coli mastitis.
06/2003	Efficacy of intramammary treatment with procaine penicillin G vs. procaine penicillin G plus neomycin in bovine clinical mastitis caused by penicillin-susceptible, gram-positive bacteria--a double blind field study.
01/2003	Efficacy of targeted 5-day combined parenteral and intramammary treatment of clinical mastitis caused by penicillin-susceptible or penicillin-resistant Staphylococcus aureus.
01/2003	Association between virulence factors and clinical course of Escherichia coli mastitis.
08/2002	Efficacy and pharmacokinetics of enrofloxacin and flunixin meglumine for treatment of cows with experimentally induced Escherichia coli mastitis.
02/2002	Virulence factors of Escherichia coli isolated from bovine clinical mastitis.

6	Mastitis 08/2004 - 02/2002
4	Infection 07/2007 - 07/2004

2	LactoferrinIBA 11/2006 - 08/2004
2	Penicillins (Penicillin)FDA Link 06/2003 - 01/2003
2	Virulence Factors (Pathogenicity Factors)IBA 01/2003 - 02/2002
1	CoagulaseIBA 07/2007
1	Penicillin G (Benzylpenicillin)FDA LinkGeneric 03/2005
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 07/2004
1	inter-alpha-inhibitorIBA 07/2004
1	Neomycin FDA LinkGeneric 06/2003
1	Procaine Penicillin G (Penicillin G Procaine)FDA Link 06/2003
1	enrofloxacinIBA 08/2002
1	flunixin meglumine (Banamine)IBA 08/2002